2009AA FDA National Drug Code Directory Source Information
Counts
(skip to: notes samples)
placeholder
| Term Type |
Description |
Count (MRCONSO.RRF) |
|
CD
|
Clinical Drug |
69050 |
|
MTH_RXN_CD
|
RxNorm Created CD |
137 |
Notes
- A term type indicates the role an atom plays in its source
- An atom is the smallest unit of naming in a source; that is, a specific string with specific code values and identifiers from a specific source.
- Every atom has a separate row in MRCONSO.RRF. Every atom is assigned a term type.
- Term types are assigned based on source documentation or NLM understanding of the source.
- Sample data are provided for every term type in the source (see below).
- See Appendix B3 for a list of all term type abbreviations and their full names.
- See Appendix B.5 for a list of sources and their associated term types, listed in default order of precedence.
- See Section 2.7.1.3.14 of UMLS Documentation for more information on MRCONSO.RRF.
Sample Data
CD
(return to top)
| CUI |
AUI |
LUI |
SUI |
CODE |
STR |
| C0361065 |
A10735309 |
L5666649 |
S6499575 |
274851 |
CEFTIBUTEN DIHYDRATE 400 MG ORAL CAPSULE [CEDAX] |
| C0687939 |
A10389745 |
L1326758 |
S2217622 |
277179 |
ATENOLOL 25 MG ORAL TABLET |
| C0688058 |
A10390836 |
L1316810 |
S2219612 |
94881 |
BUMETANIDE 0.5 MG ORAL TABLET |
| C0688143 |
A10391535 |
L1329013 |
S2220841 |
156805 |
CARISOPRODOL 350 MG ORAL TABLET |
| C0688158 |
A10391685 |
L1332042 |
S2221009 |
252599 |
CEFACLOR 500 MG ORAL CAPSULE |
| C0688319 |
A10392374 |
L1327420 |
S2222408 |
23957 |
CHLORZOXAZONE 250 MG ORAL TABLET |
| C0688320 |
A10392383 |
L1332149 |
S2222411 |
211179 |
CHLORZOXAZONE 500 MG ORAL TABLET |
| C0689726 |
A10402426 |
L1329108 |
S2237319 |
273441 |
NAPROXEN 375 MG ORAL TABLET |
| C0690278 |
A10473750 |
L2468668 |
S2921003 |
274965 |
RANITIDINE HYDROCHLORIDE 150 MG ORAL TABLET, FILM COATED |
MTH_RXN_CD
(return to top)
| CUI |
AUI |
LUI |
SUI |
CODE |
STR |
| C1962129 |
A13031862 |
L6742061 |
S7861343 |
238226 |
ADENOSINE 3 MG INTRAVENOUS INJECTION, SOLUTION [ADENOCARD]_#1 |
| C1962130 |
A13034909 |
L6741766 |
S7861344 |
238226 |
ADENOSINE 3 MG INTRAVENOUS INJECTION, SOLUTION [ADENOCARD]_#2 |
| C1965900 |
A13270242 |
L6870756 |
S7995796 |
212711 |
FLUTICASONE PROPIONATE 100 MCG / SALMETEROL XINAFOATE 50 MCG RESPIRATORY (INHALATION) INHALANT [ADVAIR]_#1 |
| C1965899 |
A13268554 |
L6872577 |
S7995797 |
212711 |
FLUTICASONE PROPIONATE 100 MCG / SALMETEROL XINAFOATE 50 MCG RESPIRATORY (INHALATION) INHALANT [ADVAIR]_#2 |
| C1966261 |
A13275104 |
L6872420 |
S8000949 |
295098 |
BUDESONIDE 160 MCG / FORMOTEROL FUMARATE DIHYDRATE 4.5 MCG ORAL SPRAY [SYMBICORT]_#1 |
| C1966262 |
A13273461 |
L6870034 |
S8000952 |
295099 |
BUDESONIDE 80 MCG / FORMOTEROL FUMARATE DIHYDRATE 4.5 MCG ORAL SPRAY [SYMBICORT]_#1 |
| C1949027 |
A13275105 |
L6873068 |
S8000953 |
295099 |
BUDESONIDE 80 MCG / FORMOTEROL FUMARATE DIHYDRATE 4.5 MCG ORAL SPRAY [SYMBICORT]_#2 |
| C1876888 |
A13270250 |
L6868852 |
S8000954 |
295099 |
BUDESONIDE 80 MCG / FORMOTEROL FUMARATE DIHYDRATE 4.5 MCG ORAL SPRAY [SYMBICORT]_#3 |
| C1966476 |
A13268880 |
L6870903 |
S7997544 |
32418 |
NASALCROM NASAL SOLUTION 40 MG/ML_#1 |
Last reviewed: 23 April 2009
Last updated: 23 April 2009
First published: 23 April 2009
Metadata| Permanence level: Permanence Not Guaranteed